Patent · US Active

Methods and compositions for modulating PD1

US10046028B2 · kind B2 · utility

6Cited by
30References
3Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 20, 2016
Grant dateAug 14, 2018
Priority date—
Expiry dateJun 22, 2036

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed herein are methods and compositions for modulating expression of a PD1 gene.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.